1
|
Schluep M, Endeman H, Gravesteijn BY, Kuijs C, Blans MJ, van den Bogaard B, Van Gemert AWMMK, Hukshorn CJ, van der Meer BJM, Knook AHM, van Melsen T, Peters R, Simons KS, Spijkers G, Vermeijden JW, Wils EJ, Stolker RJ, Hoeks SE. In-depth assessment of health-related quality of life after in-hospital cardiac arrest. J Crit Care 2021; 68:22-30. [PMID: 34856490 DOI: 10.1016/j.jcrc.2021.11.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 11/11/2021] [Accepted: 11/13/2021] [Indexed: 10/19/2022]
Abstract
INTRODUCTION Evidence on physical and psychological well-being of in-hospital cardiac arrest (IHCA) survivors is scarce. The aim of this study is to describe long-term health-related quality of life (HRQoL), functional independence and psychological distress 3 and 12 months post-IHCA. METHODS A multicenter prospective cohort study in 25 hospitals between January 2017 - May 2018. Adult IHCA survivors were included. HRQoL (EQ-5D-5L, SF-12), psychological distress (HADS, CSI) and functional independence (mRS) were assessed at 3 and 12 months post-IHCA. RESULTS At 3-month follow-up 136 of 212 survivors responded to the questionnaire and at 12 months 110 of 198 responded. The median (IQR) EQ-utility Index score was 0.77 (0.65-0.87) at 3 months and 0.81 (0.70-0.91) at 12 months. At 3 months, patients reported a median SF-12 (IQR) physical component scale (PCS) of 38.9 (32.8-46.5) and mental component scale (MCS) of 43.5 (34.0-39.7) and at 12 months a PCS of 43.1 (34.6-52.3) and MCS 46.9 (38.5-54.5). DISCUSSION Using various tools most IHCA survivors report an acceptable HRQoL and a substantial part experiences lower HRQoL compared to population norms. Our data suggest that younger (male) patients and those with poor functional status prior to admission are at highest risk of impaired HRQoL.
Collapse
Affiliation(s)
- M Schluep
- Department of Anesthesiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
| | - H Endeman
- Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - B Y Gravesteijn
- Department of Anesthesiology, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - C Kuijs
- Department of Intensive Care Medicine, Maasstad Hospital, Rotterdam, the Netherlands; Resuscitation Committee, Maasstad Hospital, Rotterdam, the Netherlands
| | - M J Blans
- Department of Intensive Care Medicine, Rijnstate Hospital, Arnhem, the Netherlands
| | - B van den Bogaard
- Department of Intensive Care Medicine, OLVG, Amsterdam, the Netherlands
| | | | - C J Hukshorn
- Department of Intensive Care Medicine, Isala Hospital, Zwolle, the Netherlands
| | | | - A H M Knook
- Department of Intensive Care Medicine, Reinier de Graaf Gasthuis, Delft, the Netherlands
| | - T van Melsen
- Department of Intensive Care Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands
| | - R Peters
- Department of Cardiology, Tergooi Hospital, Hilversum, the Netherlands
| | - K S Simons
- Department of Intensive Care Medicine, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands
| | - G Spijkers
- Department of Hospital Medicine, ZorgSaam Zeeuws-Vlaanderen, Terneuzen, the Netherlands
| | - J W Vermeijden
- Department of Intensive Care Medicine, Medisch Spectrum Twente, Enschede, the Netherlands
| | - E-J Wils
- Department of Intensive Care Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands
| | - R J Stolker
- Department of Anesthesiology, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - S E Hoeks
- Department of Anesthesiology, Erasmus University Medical Center, Rotterdam, the Netherlands
| |
Collapse
|
2
|
Grim CCA, Cornet AD, Kroner A, Meiners AJ, Brouwers AJBW, Reidinga AC, van Westerloo DJ, Bergmans DCJJ, Gommers D, Versluis D, Weller D, Christiaan Boerma E, van Driel E, de Jonge E, Schoonderbeek FJ, Helmerhorst HJF, Jongsma-van Netten HG, Weenink J, Woittiez KJ, Simons KS, van Ewelie L, Petjak M, Sigtermans MJ, van der Woude M, Cremer OL, Bijlstra P, van der Heiden P, So RKL, Vink R, Jansen T, de Ruijter W. Attitudes of Dutch intensive care unit clinicians towards oxygen therapy. Neth J Med 2020; 78:167-174. [PMID: 32641541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
BACKGROUND Over the last decade, there has been an increasing awareness for the potential harm of the administration of too much oxygen. We aimed to describe self-reported attitudes towards oxygen therapy by clinicians from a large representative sample of intensive care units (ICUs) in the Netherlands. METHODS In April 2019, 36 ICUs in the Netherlands were approached and asked to send out a questionnaire (59 questions) to their nursing and medical staff (ICU clinicians) eliciting self-reported behaviour and attitudes towards oxygen therapy in general and in specific ICU case scenarios. RESULTS In total, 1361 ICU clinicians (71% nurses, 24% physicians) from 28 ICUs returned the questionnaire. Of responding ICU clinicians, 64% considered oxygen-induced lung injury to be a major concern. The majority of respondents considered a partial pressure of oxygen (PaO2) of 6-10 kPa (45-75 mmHg) and an arterial saturation (SaO2) of 85-90% as acceptable for 15 minutes, and a PaO2 7-10 kPa (53-75 mmHg) and SaO2 90-95% as acceptable for 24-48 hours in an acute respiratory distress syndrome (ARDS) patient. In most case scenarios, respondents reported not to change the fraction of inspired oxygen (FiO2) if SaO2 was 90-95% or PaO2 was 12 kPa (90 mmHg). CONCLUSION A representative sample of ICU clinicians from the Netherlands were concerned about oxygen-induced lung injury, and reported that they preferred PaO2 and SaO2 targets in the lower physiological range and would adjust ventilation settings accordingly.
Collapse
Affiliation(s)
- C C A Grim
- Leiden University Medical Centre, Leiden, the Netherlands
| | - A D Cornet
- Leiden University Medical Centre, Leiden, the Netherlands
| | - A Kroner
- Leiden University Medical Centre, Leiden, the Netherlands
| | - A J Meiners
- Leiden University Medical Centre, Leiden, the Netherlands
| | | | - A C Reidinga
- Leiden University Medical Centre, Leiden, the Netherlands
| | | | | | - D Gommers
- Leiden University Medical Centre, Leiden, the Netherlands
| | - D Versluis
- Leiden University Medical Centre, Leiden, the Netherlands
| | - D Weller
- Leiden University Medical Centre, Leiden, the Netherlands
| | | | - E van Driel
- Leiden University Medical Centre, Leiden, the Netherlands
| | - E de Jonge
- Leiden University Medical Centre, Leiden, the Netherlands
| | | | | | | | - J Weenink
- Leiden University Medical Centre, Leiden, the Netherlands
| | - K J Woittiez
- Leiden University Medical Centre, Leiden, the Netherlands
| | - K S Simons
- Leiden University Medical Centre, Leiden, the Netherlands
| | - L van Ewelie
- Leiden University Medical Centre, Leiden, the Netherlands
| | - M Petjak
- Leiden University Medical Centre, Leiden, the Netherlands
| | - M J Sigtermans
- Leiden University Medical Centre, Leiden, the Netherlands
| | | | - O L Cremer
- Leiden University Medical Centre, Leiden, the Netherlands
| | - P Bijlstra
- Leiden University Medical Centre, Leiden, the Netherlands
| | | | - R K L So
- Leiden University Medical Centre, Leiden, the Netherlands
| | - R Vink
- Leiden University Medical Centre, Leiden, the Netherlands
| | - T Jansen
- Leiden University Medical Centre, Leiden, the Netherlands
| | - W de Ruijter
- Leiden University Medical Centre, Leiden, the Netherlands
| |
Collapse
|
3
|
Witjes M, Kotsopoulos A, Herold IHF, Otterspoor L, Simons KS, van Vliet J, de Blauw M, Festen B, Eijkenboom JJA, Jansen NE, van der Hoeven JG, Abdo WF. The Influence of End-of-Life Care on Organ Donor Potential. Am J Transplant 2017; 17:1922-1927. [PMID: 28371278 DOI: 10.1111/ajt.14286] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2016] [Revised: 03/16/2017] [Accepted: 03/18/2017] [Indexed: 01/25/2023]
Abstract
Many patients with acute devastating brain injury die outside intensive care units and could go unrecognized as potential organ donors. We conducted a prospective observational study in seven hospitals in the Netherlands to define the number of unrecognized potential organ donors outside intensive care units, and to identify the effect that end-of-life care has on organ donor potential. Records of all patients who died between January 2013 and March 2014 were reviewed. Patients were included if they died within 72 h after hospital admission outside the intensive care unit due to devastating brain injury, and fulfilled the criteria for organ donation. Physicians of included patients were interviewed using a standardized questionnaire regarding logistics and medical decisions related to end-of-life care. Of the 5170 patients screened, we found 72 additional potential organ donors outside intensive care units. Initiation of end-of-life care in acute settings and lack of knowledge and experience in organ donation practices outside intensive care units can result in under-recognition of potential donors equivalent to 11-34% of the total pool of organ donors. Collaboration with the intensive care unit and adjusting the end-of-life path in these patients is required to increase the likelihood of organ donation.
Collapse
Affiliation(s)
- M Witjes
- Department of Intensive Care Medicine, Radboud university medical center, Nijmegen, The Netherlands.,Dutch Transplant Foundation, Leiden, The Netherlands
| | - A Kotsopoulos
- Department of Intensive Care, St. Elisabeth hospital, Tilburg, The Netherlands
| | - I H F Herold
- Department of Intensive Care, Catharina hospital, Eindhoven, The Netherlands
| | - L Otterspoor
- Department of Intensive Care, Catharina hospital, Eindhoven, The Netherlands
| | - K S Simons
- Department of Intensive Care, Jeroen Bosch hospital, Den Bosch, The Netherlands
| | - J van Vliet
- Department of Intensive Care, Rijnstate hospital, Arnhem, The Netherlands
| | - M de Blauw
- Department of Intensive Care, Rijnstate hospital, Arnhem, The Netherlands
| | - B Festen
- Department of Intensive Care, Gelderse Vallei hospital, Ede, The Netherlands
| | - J J A Eijkenboom
- Department of Intensive Care, Maxima medical center, Veldhoven, The Netherlands
| | - N E Jansen
- Dutch Transplant Foundation, Leiden, The Netherlands
| | - J G van der Hoeven
- Department of Intensive Care Medicine, Radboud university medical center, Nijmegen, The Netherlands
| | - W F Abdo
- Department of Intensive Care Medicine, Radboud university medical center, Nijmegen, The Netherlands
| |
Collapse
|
4
|
Beems T, Simons KS, Van Geel WJA, De Reus HPM, Vos PE, Verbeek MM. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus. Acta Neurochir (Wien) 2003; 145:37-43. [PMID: 12545260 DOI: 10.1007/s00701-002-1019-1] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECT Hydrocephalus is characterised by elevated intracranial pressure (ICP) and gives rise to brain damage. The aim of this study was to investigate the significance of brain specific proteins as markers in the evaluation of brain damage in hydrocephalus. Therefore we determined the levels of four brain specific proteins in cerebrospinal fluid (CSF) and serum of symptomatic hydrocephalic patients. METHODS During 41 CSF shunt-operations (both primarily placed shunts and shunt-revisions) CSF and blood samples were obtained and analysed for neuron-specific enolase (NSE), S-100b, glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP). The results were compared with an age-matched control group. Patients with varying clinical symptoms, denoting different levels of increased intracranial pressure prior to surgery, were included in this study. RESULTS We observed significantly increased CSF-levels of S-100b and GFAP in the hydrocephalic patients, whereas NSE and MBP were markedly increased only in patients with very severe symptoms. Serum levels of all proteins were only minimally increased and did not correlate with CSF-levels. The slightly elevated levels of CSF-NSE in most of the patients suggest only subtle neuronal damage, which is not related to permanent neurological symptoms. The elevated levels of S-100b and GFAP are indicative of a reactive astrogliosis, which has also been demonstrated in histopathological studies. No demyelination seems to occur, according to the normal levels of MBP observed in this study. CONCLUSIONS Although CSF levels of brain specific proteins are elevated in hydrocephalic patients, indicating brain damage due to hydrocephalus, neither CSF- nor serum-concentrations of brain specific proteins seem to be valuable tools in the clinical evaluation of the severity of hydrocephalus.
Collapse
Affiliation(s)
- T Beems
- Department of Neurosurgery, University Medical Centre Nijmegen, The Netherlands
| | | | | | | | | | | |
Collapse
|
5
|
Sherk HH, Simons KS. Charges of unethical conduct made by the Camden County Medical Society against Samuel D. Gross, M.D. and Joseph Pancoast, M.D. Trans Stud Coll Physicians Phila 1998; 20:98-113. [PMID: 10207528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
|
6
|
Abstract
We have determined the complete nucleotide sequence of the two nonallelic adult beta-globin genes of the C57BL/10 mouse. These genes, designated beta s and beta t, show a sequence similarity of 99.6% over the region bordered by the translational start and stop codons. Both beta s and beta t encode functional polypeptide chains that are identical. A comparison of the C57BL/10 beta-globin haplotype, Hbbs, with that of the BALB/c mouse, Hbbd, suggests that the two haplotypes have distinct evolutionary histories. The two adult beta-globin genes of the Hbbd haplotype, beta dmaj and beta dmin, are 16% divergent at the nucleotide level and encode distinct polypeptides that are synthesized in differing amounts. Our analysis indicates that a gene correction mechanism has been operating on the Hbbs chromosome to keep beta s and beta t evolving in concert, whereas on the Hbbd chromosome, beta dmin has diverged considerably from beta dmaj. We suggest that gene conversion is responsible for the maintained similarity of the Hbbs genes. Furthermore, we attribute the divergence of the Hbbd genes in part to the absence of a region of simple-sequence DNA within the large intervening sequence of beta dmin. We propose that this region of DNA plays a role in facilitating gene conversion. The deletion of this area in beta dmin introduced a block of nonhomology between the beta dmaj-beta dmin gene pair and thus may have inhibited further gene correction within the Hbbd haplotype.
Collapse
Affiliation(s)
- M A Erhart
- Department of Biological Sciences, University of Illinois, Chicago 60680
| | | | | |
Collapse
|